Pulmonary infection caused by Achromobacter xylosoxidans in a patient with carcinoma of epiglottis: A rare case

Journal of Clinical and Diagnostic Research

Volumn 8, Issue 5, 2014, Pages

  Roy, Priyamvada ^a  

^a Care of Group Captain D D Roy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE;

ACHROMOBACTER XYLOSOXIDANS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BONE MARROW SUPPRESSION; CASE REPORT; CHILL; DISEASE SURVEILLANCE; DYSPNEA; EPIGLOTTIS CANCER; FEVER; GRAM STAINING; HUMAN; INDIA; LEUKOPENIA; LUNG INFECTION; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MONOCYTOSIS; SPUTUM ANALYSIS; SUPPURATION; WEAKNESS;

EID: 84901275332     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2014/7940.4329     Document Type: Article

References (12)

1. Claassen SL, Reese JM, Mysliwiec V, Mahlen SD. Achromobacter xylosoxidans infection presenting as a pulmonary nodule mimicking cancer. J Clin Microbiol. July 2011; 49(7):2751-4.
2. Eshwara VK, Mukhopadhyay C, Mohan S, Prakash R, Pai G. Two unique presentations of Achromobacter xylosoxidans infections in clinical settings. J Infect Dev Ctries. 2011;5(2):138-41.
3. Shie SS, Huang CT, Leu HS. Characteristics of Achromobacter xylosoxidans Bacteremia in Northern Taiwan. J Microbiol Immunol Infect. 2005;38:277-82.
4. Garrity GM, Brenner DJ, Kreig NR, Staley JT, eds. Bergey's Manual of Systematic Bacteriology, 2nd ed, Springer-Verlag: New York-Berlin-Heidelberg.2005;2: 658-9.
5. Aisenberg G, Rolston KV, Safdar A. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer. 2004; 101: 2134-40.
6. Gomez-Cerezo J, Suarez I, Rios JJ, Pena P, Garcia de Miguel MJ, de Jose M, et al.,. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis. 2003; 22:360-3.
7. Teng SO, Ou TY, Hsieh YC, Lee WC, Lin YC, Lee WS. Complicated Intra-abdominal Infection Caused by Extended Drug Resistant Achromobacter xylosoxidans. J Microbiol Immunol Infect. 2009;42:176-80.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty third Informational supplement. CLSI document. M100-S23, 2013.
9. Saiman L, Chen Y, Tabibi S, Gabriel PS, Zhou J, Liu Z, et al. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol. 2001; 39: 3942-5.
10. Legrand C, Anaissie E. Bacteremia due to Achromobacter xylosoxidans in patients with cancer. Clin Infect Dis. 1992; 14:479-84.
11. Arroyo JC, Jordan W, Lema MW, Brown A. Diversity of plasmids in Achromobacter xylosoxidans isolates responsible for a seemingly common-source nosocomial outbreak. J Clin Microbiol. 1987;25:1952-5.
12. Reverdy ME, Freney J, Fleurette J, Coulet M, Surgot M, Marmet D, et al. Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol. 1984;19: 140-3.